Cardinal Health Director Sells $704,549 in Stock (CAH)
Cardinal Health (NYSE:CAH) Director Richard C. Notebaert sold 10,727 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $65.68, for a total transaction of $704,549.36. Following the completion of the transaction, the director now directly owns 33,750 shares of the company’s stock, valued at approximately $2,216,700. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Cardinal Health (NYSE:CAH) traded down 0.29% on Wednesday, hitting $65.37. The stock had a trading volume of 2,599,201 shares. Cardinal Health has a one year low of $41.42 and a one year high of $69.51. The stock has a 50-day moving average of $67.12 and a 200-day moving average of $58.66. The company has a market cap of $22.357 billion and a price-to-earnings ratio of 60.20.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.79 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.84 by $0.05. The company had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $20.74 billion. Analysts expect that Cardinal Health will post $3.82 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of 0.3025 per share. This represents a $1.21 dividend on an annualized basis and a yield of 1.85%.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated an “outperform” rating on shares of Cardinal Health in a research note to investors on Tuesday. They now have a $83.00 price target on the stock. Separately, analysts at Sterne Agee raised their price target on shares of Cardinal Health from $73.00 to $83.00 in a research note to investors on Friday, January 31st. Finally, analysts at Raymond James raised their price target on shares of Cardinal Health from $75.00 to $77.00 in a research note to investors on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $67.36.
Cardinal Health, Inc is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.